EICHOR
● Active Not Recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Condition: Chronic Obstructive Pulmonary Disease · Sponsor: Upstream Bio Inc.
About this study
The purpose of this study is to assess the efficacy and safety of verekitug (UPB-101) in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), an inflammatory lung disease.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (242)
| Kern Research Inc. | Bakersfield, California, United States | — |
| PulmoCrit Associates | Encino, California, United States | — |
| Torrance Clinical Research Institute | Lomita, California, United States | — |
| Dream Team Clinical Research | Pomona, California, United States | — |
| Apex Clinical Research | San Diego, California, United States | — |
| Allianz Research Institute | Westminster, California, United States | — |
| D&H Doral Research Center, LLC | Doral, Florida, United States | — |
| Qway Research, LLC | Hialeah, Florida, United States | — |
| Finlay Medical Research | Miami, Florida, United States | — |
| MplusM - ITB Research | Miami, Florida, United States | — |
| Florida Institute for Clinical Research,LLC | Orlando, Florida, United States | — |
| Velocity Clinical Research-Savannah - Internal Medicine | Savannah, Georgia, United States | — |
+ 230 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06981078